Pays: Irlande
Langue: anglais
Source: HPRA (Health Products Regulatory Authority)
PRAZIQUANTEL, PYRANTEL EMBONATE, FEBANTEL
Bayer Limited
QP52AF30
PRAZIQUANTEL, PYRANTEL EMBONATE, FEBANTEL
50/144/150
Tablets
CAM-Companion Animal Medicine
Canine
Combinations of tetrahydropyrimidines
Endoparasiticide
Authorised
2009-01-25
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Drontal Plus Flavour Tablets for Dogs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Tablet. A light brown to brown, round, flat tablet, cross scored on one side for oral administration to dogs. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the control of the following gastrointestinal tapeworms and roundworms in dogs and puppies. Ascarids: _Toxocara canis, Toxascaris leonina_ (adult and late immature forms). Hookworms: _Uncinaria stenocephala, Ancylostoma caninum_ (adults) Whipworms: _Trichuris vulpis_ (adults) Tapeworms: _Echinococcus_ spp.,_ Taenia_ spp.,_ Dipylidium caninum_ (adult and immature forms) 4.3 CONTRAINDICATIONS Do not use simultaneously with piperazine compounds. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES As a precautionary measure to prevent establishment of _Echinococcus multilocularis_ in the UK and Ireland it is recommended that all dogs and cats entering the country be treated with praziquantel. Fleas serve as intermediate hosts for one common type of tapeworm-_Dipylidium caninum_. Tapeworm infestation is certain to re-occur unless control of intermediate hosts such as fleas, mice etc is undertaken. Each tablet contains: mg per tablet Febantel 150.0 Pyrantel embonate 144.0 Praziquantel 50.0 EXCIPIENTS Artificial beef flavour, irradiated 116.5 For the full list of excipients see section 6.1. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ Lire le document complet